Exane Derivatives’s Chemours CC Stock Holding History

Exane Derivatives’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.67K	Hold	52	–	–	﹤0.01%	458
2022 Q1	$1.64K	Hold	52	–	–	﹤0.01%	770
2021 Q4	$1.75K	Hold	52	–	–	﹤0.01%	668
2021 Q3	$1.51K	Hold	52	–	–	﹤0.01%	823
2021 Q2	$1.76K	Hold	52	–	–	﹤0.01%	827
2021 Q1	$1.45K	Hold	52	–	–	﹤0.01%	704
2020 Q4	$1.29K	Hold	52	–	–	﹤0.01%	661
2020 Q3	$1.09K	Hold	52	–	–	﹤0.01%	613
2020 Q2	$798	Hold	52	–	–	﹤0.01%	567
2020 Q1	$461	Hold	52	–	–	﹤0.01%	606
2019 Q4	$923	Hold	52	–	–	﹤0.01%	549
2019 Q3	$777	Sell	52 -684	-93%	-$11.1K	﹤0.01%	555
2019 Q2	$17.7K	Buy	736 +626	+569%	+$18.4K	﹤0.01%	430
2019 Q1	$4.09K	Sell	110 -133,772	-100%	-$4.87M	﹤0.01%	417
2018 Q4	$3.78M	Buy	+133,882	New	+$4.23M	0.68%	32
2018 Q3	–	Sell	-45,677	Closed	-$2.03M	–	700
2018 Q2	$2.03M	Buy	45,677 +45,528	+30,556%	+$2.26M	0.34%	74
2018 Q1	$6.94K	Hold	149	–	–	﹤0.01%	430
2017 Q4	$7.45K	Hold	149	–	–	﹤0.01%	416
2017 Q3	$7.54K	Hold	149	–	–	﹤0.01%	416
2017 Q2	$5.65K	Hold	149	–	–	﹤0.01%	428
2017 Q1	$5.74K	Hold	149	–	–	﹤0.01%	371
2016 Q4	$3.29K	Hold	149	–	–	﹤0.01%	444
2016 Q3	$2.38K	Hold	149	–	–	﹤0.01%	461
2016 Q2	$1.23K	Hold	149	–	–	﹤0.01%	422
2016 Q1	$1.04K	Hold	149	–	–	﹤0.01%	473
2015 Q4	$799	Hold	149	–	–	﹤0.01%	410
2015 Q3	$964	Buy	+149	New	+$1.56K	﹤0.01%	429

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Exane Derivatives's CC Position: Q2 2022 in Review

Exane Derivatives held its Chemours (CC) position steady in Q2 2022 at 52 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #458.

Exane Derivatives first reported a position in CC in Q3 2015 and has held it in 27 quarters since. The position peaked at $3.78M in Q4 2018. 517 funds tracked by Wall St. Rank hold CC as of Q2 2022.

Exane Derivatives held 52 shares of Chemours worth $1.67K as of Q2 2022.
Exane Derivatives left its Chemours share count unchanged in Q2 2022.
Chemours made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #458 holding.
Exane Derivatives first reported a position in Chemours in Q3 2015 and has held it in 27 quarters since.
Exane Derivatives's Chemours position peaked at $3.78M in Q4 2018.
517 funds tracked by Wall St. Rank held Chemours as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.